UPDATE: BMO Capital Maintains Gilead Sciences (GILD) at Market Perform (Correction)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. FDX
3. KBH
4. HON
5. HTZ
6. MRK
7. TTWO
8. USO
9. QCOM
10. INFY

Go back to UPDATE: BMO Capital Maintains Gilead Sciences (GILD) at Market Perform (Correction)

Gilead Sciences (GILD) Misses Q3 EPS by 11c; Reiterates Outlook

November 1, 2016 4:03 PM EDT

Gilead Sciences (NASDAQ: GILD) reported Q3 EPS of $2.75, $0.11 worse than the analyst estimate of $2.86. Revenue for the quarter came in at $7.4 billion versus the consensus estimate of $7.45 billion.Gilead Sciences reaffirmed FY2016... More